Quality of Life in Lung Cancer Survivors

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00586937

Enrollment

193

Registered

2008-01-07

Start date

2005-06-30

Completion date

2020-01-02

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer Survivors

Keywords

Lung Cancer Survivors

Brief summary

The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. Learning about quality of life will help us to develop new services for lung cancer survivors.

Interventions

BEHAVIORALquestionnaires or telephone interview

In the first phase, a random sample of lung cancer survivors will complete a comprehensive telephone interview or questionnaire by self-report focusing on assessment of quality of life and related covariates. We estimate the total time for completion of the survey by telephone interview or self-report to be 45-60 minutes. second phase of the study, a subset of telephone survey participants will take part in a focus group discussion that will explore their perceptions of barriers for delivery of post-treatment medical and psychosocial follow-up care.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Diagnosis of primary Stage IA or IB NSCLC; * Underwent surgical resection for NSCLC at MSKCC; * From 1 to 5 years and 11 months post-treatment for NSCLC prior to study recruitment; * No evidence of disease (NED) at the time of recruitment; * Can be reached by telephone; * Able to provide informed consent.

Exclusion criteria

* Undergoing active antineoplastic treatment; * Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.

Design outcomes

Primary

Measure	Time frame
To describe the health-related quality of life (HQOL) of lung cancer survivors and compare their HQOL with age- and gender-appropriate, population-based normative data.	2 years

Secondary

Measure	Time frame
To describe and identify covariates of HQOL in lung cancer survivors.	2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026